Petros Pharmaceuticals, Inc. (PTPI) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$6.73M | -158.7% |
| 2024 | -$2.60M | +65.9% |
| 2023 | -$7.63M | +40.4% |
| 2022 | -$12.80M | -7.9% |
| 2021 | -$11.86M | +22.5% |
| 2020 | -$15.31M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$6.73M | -158.7% |
| 2024 | -$2.60M | +65.9% |
| 2023 | -$7.63M | +40.4% |
| 2022 | -$12.80M | -7.9% |
| 2021 | -$11.86M | +22.5% |
| 2020 | -$15.31M | — |